[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 23,487
Citations 0
Viewpoint
October 4, 2016

Toward a New Era of Trust and Transparency in Clinical Trials

Author Affiliations
  • 1National Institutes of Health, Bethesda, Maryland
JAMA. 2016;316(13):1353-1354. doi:10.1001/jama.2016.14668

Clinical trials are the most publicly visible component of the biomedical research enterprise, from the potential human application of novel laboratory findings to the generation of robust evidence about treatments or preventive interventions in routine clinical care. These trials are also the point at which biomedical research most directly engages human participants—dedicated volunteers who trust investigators to uphold the highest standards of scientific rigor and ethical oversight. While clinical trials have evolved and improved over time—producing impressive advances in diagnosis, treatment, and prevention—there are still major challenges. Therefore, fundamental changes are needed to reflect science and society’s movement to increase efficiency, accountability, and transparency in clinical research.

First Page Preview View Large
First page PDF preview
First page PDF preview
×